You are here

CEPI

Valneva gets $41m grant to roll out chikungunya vaccine

Pharmaphorum

Mon, 07/22/24 - 11:28 am

chikungunya virus

Moderna joins CEPI's 100 Days Mission to advance pandemic preparedness

Fierce Biotech

Mon, 10/30/23 - 10:19 am

Moderna Therapeutics

Researchers behind AstraZeneca's COVID shot reunite to prepare for future pathogens

Fierce Biotech

Wed, 08/30/23 - 11:00 am

University of Oxford

EpiVax partners with Intravacc, CEPI for betacoronavirus vaccine development

Pharmaceutical Business Review

Tue, 11/1/22 - 11:01 am

betacoronaviruses

Codiak gets $2.5M from CEPI to forge way out of pandemic, prep for disease X

Biopharma Reporter

Thu, 07/7/22 - 10:25 am

pan-coronavirus vaccine

Codiak Biosciences

CEPI to expand COVID-19 vaccine testing network to other epidemic and pandemic diseases

Biopharma Reporter

Tue, 11/23/21 - 09:45 am

Oral vaccines and novel tech: CEPI announces grants for ‘variant-proof’ COVID-19 vaccine development

Biopharma Reporter

Fri, 11/5/21 - 12:52 pm

drug development

COVID-19 variants

CEPI warns of major hurdle to developing new Covid-19 vaccines and studying best booster approaches

Stat

Tue, 09/7/21 - 10:42 am

Gritstone secures CEPI funding to test Covid vaccine; first focus is South Africa

MedCity News

Tue, 08/17/21 - 10:53 pm

WHO, global partners launch $18B COVID-19 vaccine initiative

Fierce Pharma

Fri, 06/26/20 - 08:10 pm

Vaccine alliance finds manufacturing capacity for 4 billion doses of coronavirus vaccines

Reuters

Thu, 06/25/20 - 11:02 am

drug manufacturing

Novavax scores $384M deal, CEPI's largest ever, to fund coronavirus vaccine work

Fierce Pharma

Mon, 05/11/20 - 11:44 pm

drug development

Novavax Receives $4 Million in Funding to Develop a Vaccine for COVID-19

Motley Fool

Tue, 03/10/20 - 11:19 pm

Has pharma been too slow to respond to coronavirus?

Pharmaforum

Mon, 02/3/20 - 10:28 am

Wuhan Coronavirus

Moderna Therapeutics

British drugmaker GSK to collaborate with CEPI in effort to develop coronavirus vaccine

Reuters

Sun, 02/2/20 - 11:56 pm

Wuhan Coronavirus

Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS

CP Wire

Wed, 04/11/18 - 11:59 pm

Inovio Awarded up to $56 Million from Epidemic Prevention Coalition to Advance DNA Vaccines Against Lassa Fever and MERS

Wed, 04/11/18 - 12:18 pm